Ultraprocessed foods: A majority of the American diet, and a majority bad for health
CDC, American Heart Association publish reports quantifying consumption and offering policy recommendations.
CDC, American Heart Association publish reports quantifying consumption and offering policy recommendations.
Panelists discuss how trastuzumab deruxtecan demonstrated a 22% overall response rate in patients with biliary tract cancer (56.3% in HER2 3+ patients) with 7.4 months…
Multiple FDA-approved drugs without lipid-lowering indications were identified to have potential lipid-lowering properties.
Exclusive results of a survey of Medical Economics’ physician audience.
SWIFT-seq revolutionizes multiple myeloma diagnosis, offering a noninvasive blood test that enhances monitoring and risk assessment for patients.
Patients’ preferences for physicians’ attire depend on setting, specialty and physician gender, review shows.
High Intensity Use (HIU) programmes offer targeted outpatient appointments to those attending emergency departments (EDs) at significantly higher rates than the general population. They are…
Explore the latest insights on value-based care, physician debt, and essential practice tips in the interactive July/August 2025 edition of Medical Economics Insider.
The action is supported by positive safety and efficacy findings from the phase 1a/1b first-in-human Beamion LUNG-1 trial.
Residency programs that combine basic internal medicine training with other disciplines are also available. These combined programs almost always allow completion of training and eligibility…
Marschall Runge, M.D., Ph.D., joins the show to talk about what’s wrong with U.S. health care — and what we can do about it.